Treatment Relapsed Subcutaneous Panniculitis-like T-Cell Lymphoma together HPS by Cyclosporin A
Department of Haematology, Tang du Hospital, Fourth Military Medical University, Xi’an 710038, China
*
Author to whom correspondence should be addressed.
Hematol. Rep. 2010, 2(1), e9; https://doi.org/10.4081/hr.2010.e9
Submission received: 29 September 2010
/
Revised: 20 November 2010
/
Accepted: 23 November 2010
/
Published: 30 November 2010
Abstract
A 25-year-old man was diagnosised subcutaneous panniculitis-like T-cell lymphoma (SPTCL) through biopsy of a nodule from the anterior chest. After the treatment with prednisone 90 mg 3 weeks and tapered off in 1 month, the disease released, but relapsed together with symptions of hemophagocytic syndrome eight months after the termination of prednisone. CHOEP recipe was given but with unsatisfactory result until cyclosporine was prescribed. Cyclosporine was removed 6 months later. There is no evidence of clinical relapse 1 year later. This case suggest that cyclosporine could be a selectable treatment even in relapsed SPTCL.
Share and Cite
MDPI and ACS Style
Chen, R.; Liu, L.; Liang, Y. Treatment Relapsed Subcutaneous Panniculitis-like T-Cell Lymphoma together HPS by Cyclosporin A. Hematol. Rep. 2010, 2, e9. https://doi.org/10.4081/hr.2010.e9
AMA Style
Chen R, Liu L, Liang Y. Treatment Relapsed Subcutaneous Panniculitis-like T-Cell Lymphoma together HPS by Cyclosporin A. Hematology Reports. 2010; 2(1):e9. https://doi.org/10.4081/hr.2010.e9
Chicago/Turabian StyleChen, Ren'an, Li Liu, and Yinmin Liang. 2010. "Treatment Relapsed Subcutaneous Panniculitis-like T-Cell Lymphoma together HPS by Cyclosporin A" Hematology Reports 2, no. 1: e9. https://doi.org/10.4081/hr.2010.e9
